2052-2975

New Microbes and New Infections

Elsevier

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 1843 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact1843 DOIs
2

Attach ORCID iDs across 1180 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1180 DOIs
3

Deposit reference lists for 55 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact55 DOIs

DOIs for this ISSN

Showing the top 5 of 1833 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 The global threat of antimicrobial resistance: science for i… (10.1016/j.nmni.2015.02.007)
Abstract ORCID
146.67 857
2 Bacterial culture through selective and non-selective condit… (10.1016/j.nmni.2019.100622)
Abstract ORCID
126.70 341
3 The bacterial pangenome as a new tool for analysing pathogen… (10.1016/j.nmni.2015.06.005)
Abstract ORCID
121.73 271
4 COVID-19 and intracerebral haemorrhage: causative or coincid… (10.1016/j.nmni.2020.100669)
Abstract ORCID
118.55 234
5 Emerging infectious diseases in Africa in the 21st century (10.1016/j.nmni.2018.09.004)
Abstract ORCID
108.51 147
6 Prevalence and pathogenicity of binary toxin–positive Clostr… (10.1016/j.nmni.2014.10.003)
Abstract ORCID
103.22 115
7 ‘ Candidatus Neoehrlichia mikurensis’ in Europe (10.1016/j.nmni.2017.12.011)
Abstract ORCID
103.03 114
8 adeABC efflux gene in Acinetobacter baumannii (10.1016/j.nmni.2019.100549)
Abstract ORCID
100.85 103
9 Epidemiology, genome, and clinical features of the pandemic… (10.1016/j.nmni.2020.100672)
Abstract ORCID
100.00 99
10 A severe case of persistent diarrhoea associated with Arcoba… (10.1002/2052-2975.35)
Abstract ORCID
98.19 91
11 Real-time quantitative PCR assay with Taqman ® probe for rap… (10.1016/j.nmni.2016.06.017)
Abstract ORCID
97.95 90
12 Treponema species enrich the gut microbiota of traditional r… (10.1016/j.nmni.2018.10.009)
Abstract ORCID
97.71 89
13 Clinical features of endemic community-acquired psittacosis (10.1002/2052-2975.29)
Abstract ORCID
95.15 79
14 The importance of Faecalibacterium prausnitzii in human heal… (10.1016/j.nmni.2021.100928)
Abstract ORCID
94.32 76
15 Corrigendum to “The global threat of antimicrobial resistanc… (10.1016/j.nmni.2015.09.004)
Abstract References ORCID
94.15 17
16 Rapid identification of carbapenemase-producing Enterobacter… (10.1016/j.nmni.2015.07.001)
Abstract ORCID
92.56 70
17 Oral probiotics in coronavirus disease 2019: connecting the… (10.1016/j.nmni.2021.100837)
Abstract ORCID
92.56 70
18 Insertional inactivation of oprD in carbapenem-resistant Pse… (10.1016/j.nmni.2017.10.013)
Abstract ORCID
91.94 68
19 Persistence of nasal colonization with human pathogenic bact… (10.1016/j.nmni.2015.11.004)
Abstract ORCID
90.65 64
20 SARS-CoV-2 and Plasmodium falciparum common immunodominant r… (10.1016/j.nmni.2020.100817)
Abstract ORCID
90.65 64
21 Haemolytic-uraemic syndrome with bacteraemia caused by a new… (10.1002/nmi2.49)
Abstract ORCID
89.62 61
22 Potential use of hydroxychloroquine, ivermectin and azithrom… (10.1016/j.nmni.2020.100684)
Abstract ORCID
89.27 60
23 Antimicrobial peptides of the vaginal innate immunity and th… (10.1016/j.nmni.2019.100627)
Abstract ORCID
88.54 58
24 Simultaneous outbreaks of dengue, chikungunya and Zika virus… (10.1016/j.nmni.2016.02.003)
Abstract ORCID
88.17 57
25 Changing trends in the epidemiology of vertebral osteomyelit… (10.1016/j.nmni.2015.04.008)
Abstract ORCID
87.79 56
26 Epidemiology of Clostridium difficile infection in two terti… (10.1002/nmi2.43)
Abstract ORCID
87.41 55
27 Diversity of viruses in Ixodes ricinus, and characterization… (10.1016/j.nmni.2016.02.012)
Abstract ORCID
87.41 55
28 Clinical efficacy of chloroquine derivatives in COVID-19 inf… (10.1016/j.nmni.2020.100709)
Abstract ORCID
87.41 55
29 Knowledge, attitude, practice and psychological response tow… (10.1016/j.nmni.2020.100787)
Abstract ORCID
87.41 55
30 Candidatus ‘Rickettsia senegalensis’ in cat fleas in Senegal (10.1016/j.nmni.2014.10.005)
Abstract ORCID
87.02 54
31 Mansonellosis, the most neglected human filariasis (10.1016/j.nmni.2018.08.016)
Abstract ORCID
87.02 54
32 Consideration of dornase alfa for the treatment of severe CO… (10.1016/j.nmni.2020.100689)
Abstract ORCID
87.02 54
33 Genotyping of methicillin-resistant Staphylococcus aureus in… (10.1002/nmi2.47)
Abstract ORCID
86.62 53
34 High seroprevalence of Borrelia miyamotoi antibodies in fore… (10.1002/nmi2.59)
Abstract ORCID
86.62 53
35 Clinical and immunologic features among COVID-19–affected mo… (10.1016/j.nmni.2020.100752)
Abstract ORCID
86.21 52
36 Relationship between blood group and risk of infection and d… (10.1016/j.nmni.2020.100743)
Abstract ORCID
85.80 51
37 COVID-19 reinfection: prolonged shedding or true reinfection… (10.1016/j.nmni.2020.100812)
Abstract ORCID
85.38 50
38 Laboratory diagnosis of SARS-CoV-2: available approaches and… (10.1016/j.nmni.2020.100713)
Abstract ORCID
84.95 49
39 Development of a high throughput PCR to detect Coxiella burn… (10.1002/2052-2975.8)
Abstract ORCID
84.51 48
40 Epidemiology of Staphylococcus aureus in Bangalore, India: e… (10.1016/j.nmni.2015.05.003)
Abstract ORCID
84.51 48
41 Role of Tsukamurella species in human infections: first lite… (10.1016/j.nmni.2017.10.002)
Abstract ORCID
84.51 48
42 Prevalence and antibiotic susceptibility pattern of uropatho… (10.1016/j.nmni.2020.100716)
Abstract ORCID
84.51 48
43 International Mycoplasma pneumoniae typing study: interpreta… (10.1016/j.nmni.2015.05.005)
Abstract ORCID
83.60 46
44 Chikungunya outbreak in Delhi, India, 2016: report on coinfe… (10.1016/j.nmni.2017.07.007)
Abstract ORCID
83.60 46
45 Distribution and antimicrobial activity of lactic acid bacte… (10.1016/j.nmni.2019.100560)
Abstract ORCID
83.60 46
46 Multi-drug resistance and reduced susceptibility to ciproflo… (10.1002/nmi2.46)
Abstract ORCID
83.14 45
47 Molecular characterization of Acinetobacter baumannii isolat… (10.1016/j.nmni.2017.10.010)
Abstract ORCID
83.14 45
48 Transmission routes for SARS-CoV-2 infection: review of evid… (10.1016/j.nmni.2020.100778)
Abstract ORCID
83.14 45
49 Development of a novel platform of virus-like particle (VLP)… (10.1016/j.nmni.2020.100786)
Abstract ORCID
83.14 45
50 Persistence of anti–chikungunya virus–specific antibodies in… (10.1016/j.nmni.2015.04.002)
Abstract ORCID
82.66 44